Abstract: A radome structure may include an inner tuning layer component and a laminate component overlying the inner tuning layer component. The inner tuning layer component may include a thermoset foam or a thermoplastic foam. The laminate component may include a first fiber reinforced dielectric layer, a second fiber reinforced dielectric layer overlying the first fiber reinforced dielectric layer, and a third fiber reinforced dielectric layer overlying the second fiber reinforced dielectric layer. The first fiber reinforced dielectric layer may include a first low dielectric constant material. The second fiber reinforced dielectric layer may include a first high dielectric constant material. The third fiber reinforced dielectric layer may include a second low dielectric constant material.

Abstract: Techniques for secure and efficient interfacing with a cloud computing service are described. In an embodiment, a cloud computing management service is programmed or configured to communicate with a cloud computing service. The cloud computing management service can be accessed by software engineers that are looking to deploy a software instance to a computing device of the cloud computing service. Thus, the cloud computing management service acts as an intermediary layer in front of the cloud computing service. In an embodiment, the cloud computing management service may store one or more frequently-used system parameters for deployment of software instances. The parameters conform to company's security protocols, compliance protocols, and/or other standards.

Abstract: The present application is directed to the field of implants comprising soft tissue for use in implantation in humans. The soft tissue implants of the present application are preferably obtained from xenograft sources. The present application provides a chemical process that sterilizes, removes antigens from and/or strengthens xenograft implants. The present techniques yield soft tissue implants having superior structural, mechanical, and/or biochemical integrity. The present application is also directed to processes for treating xenograft implants comprising soft tissues such as dermis, and to implants produced by such processes.

Abstract: This invention relates to novel whitening agents for cellulosic substrates. The whitening agents are comprised of at least two components: at least one chromophore component and at least one polymeric component. Suitable chromophore components generally fluoresce blue, red, violet, or purple color when exposed to ultraviolet light, or they may absorb light to reflect these same shades. The whitening agents are further characterized by having a dispersion component value of the Hansen Solubility Parameter of less than or equal to about 17 MPa0.5. This invention also relates to laundry care compositions including but not limited to liquid and/or powder laundry detergent formulations and rinse added fabric softening (RAFS) compositions that comprise such whitening agents.

Abstract: The present application is directed to the field of implants comprising soft tissue for use in implantation in humans. The soft tissue implants of the present application are preferably obtained from xenograft sources. The present application provides a chemical process that sterilizes, removes antigens from and/or strengthens xenograft implants. The present techniques yield soft tissue implants having superior structural, mechanical, and/or biochemical integrity. The present application is also directed to processes for treating xenograft implants comprising soft tissues such as dermis, and to implants produced by such processes.

Abstract: Systems and methods for well flowback monitoring include connecting wells to a test separator and a commingle separator; solitarily coupling a first well to the test separator; measuring output values of the first well via the test separator; coupling the first well to the commingle separator; solitarily coupling a second well to the test separator; measuring output values of the second well with the test separator; taking measurements via the commingle separator of a subset of the wells including the first well and not including the second well; determining an interpolated value of the first well; and using the interpolated value against the measurements of the commingle separator to determine a percentage of a total relating to the first well; each well is rotated through the test separator, the associated output values used to determine associated interpolated values for use with measurements taken via the commingle separator.

Abstract: The present application is directed to the field of implants comprising soft tissue for use in implantation in humans. The soft tissue implants of the present application are preferably obtained from xenograft sources. The present application provides a chemical process that sterilizes, removes antigens from and/or strengthens xenograft implants. The present techniques yield soft tissue implants having superior structural, mechanical, and/or biochemical integrity. The present application is also directed to processes for treating xenograft implants comprising soft tissues such as dermis, and to implants produced by such processes.

Abstract: The present application is directed to the field of implants comprising soft tissue for use in implantation in humans. The soft tissue implants of the present application are preferably obtained from xenograft sources. The present application provides a chemical process that sterilizes, removes antigens from and/or strengthens xenograft implants. The present techniques yield soft tissue implants having superior structural, mechanical, and/or biochemical integrity. The present application is also directed to processes for treating xenograft implants comprising soft tissues such as dermis, and to implants produced by such processes.

Abstract: A sand trap for oil and gas extraction includes a cyclonic flow section having a longitudinal axis, an inlet for receiving a high-pressure fluid stream with particulates, an upper portion, a choke area, and a funnel portion narrowing from the upper portion to the choke area. The inlet has an axis generally perpendicular but askew to the longitudinal axis. A vortex finder extends downwardly from a cap and defines a passageway coaxial with the longitudinal axis for fluid to exit. A spherical accumulator extends downwardly from the cyclonic flow section and has a center axis coaxial with the longitudinal axis. Upper and lower ends of the spherical accumulator each have an opening centered along the longitudinal axis, and the spherical accumulator is unobstructed from the upper opening to the lower opening for the particulates to pass unimpeded and accumulate in the accumulator.

Abstract: Disclosed are puzzle devices for production of one or more puzzles. The puzzle devices can include a body and at least one input device. The body can include a plurality of panels, each panel configured to display one or more visual indicators. The at least one input device can include a plurality of panels, each panel configured to display a visual indicator. The at least one input device can move relative to the body to align one or more panels of the input device with one or more panels of the body. The body can further include a plurality of visual output devices configured to generate visual indicators on the plurality of panels of the body.

Abstract: The present application is directed to the field of implants comprising soft tissue for use in implantation in humans. The soft tissue implants of the present application are preferably obtained from xenograft sources. The present application provides a chemical process that sterilizes, removes antigens from and/or strengthens xenograft implants. The present techniques yield soft tissue implants having superior structural, mechanical, and/or biochemical integrity. The present application is also directed to processes for treating xenograft implants comprising soft tissues such as dermis, and to implants produced by such processes.

Abstract: A sand trap for use in oil and gas extraction operations includes a cylindrical vessel for receiving a high-pressure fluid stream with particulates. The vessel has a vertical longitudinal axis and a hollow cylindrical wall having upper and lower ends and an inlet opening generally perpendicular to but askew to the vessel longitudinal axis. Upper and lower caps extend from the upper and lower ends and have openings along the vessel longitudinal axis. An annular diverter has top and bottom ends and a longitudinal axis coaxial with the vessel longitudinal axis. A diverter outer wall permanently extends from an inner face of the cylindrical wall, and a diverter inner wall has an upper portion narrowing to a choke area and a lower portion flaring out from the choke area. A vent pipe extends from the upper cap opening to a location between the upper cap and the diverter top end.

Abstract: A sand trap for use in oil and gas extraction operations includes a cylindrical vessel for receiving a high-pressure fluid stream with particulates. The vessel has a vertical longitudinal axis and a hollow cylindrical wall having upper and lower ends and an inlet opening generally perpendicular to but askew to the vessel longitudinal axis. Upper and lower caps extend from the upper and lower ends and have openings along the vessel longitudinal axis. An annular diverter has top and bottom ends and a longitudinal axis coaxial with the vessel longitudinal axis. A diverter outer wall permanently extends from an inner face of the cylindrical wall, and a diverter inner wall has an upper portion narrowing to a choke area and a lower portion flaring out from the choke area. A vent pipe extends from the upper cap opening to a location between the upper cap and the diverter top end.

Abstract: The present application is directed to the field of implants comprising soft tissue for use in implantation in humans. The soft tissue implants of the present application are preferably obtained from xenograft sources. The present application provides a chemical process that sterilizes, removes antigens from and/or strengthens xenograft implants. The present techniques yield soft tissue implants having superior structural, mechanical, and/or biochemical integrity. The present application is also directed to processes for treating xenograft implants comprising soft tissues such as dermis, and to implants produced by such processes.

Abstract: There is provided an article being moveable between a first position and a second position and biased to the second position. The article is retained in the first position by retaining means until a predetermined condition is met, wherein when that predetermined condition is met, biasing means exert a biasing force to move the article from the first position to the second position. The predetermined condition is met when at least one formation, located on at least one face of the article, is moved from a first position to a second position, thereby releasing the retaining means and permitting movement of the article from the first position to the second position. Also provided is a group of at least two articles provided to interact with one another, with one article meeting the predetermined condition for moving the other from the first position to the second position.

Abstract: The present application relates to novel substituted 5,6,7,8-tetrahydro[1,2,4]triazolo[4,3-a]pyridin-3(2H)-ones and 2,5,6,7-tetrahydro-3H-pyrrolo[2,1-c][1,2,4]triazol-3-ones, to processes for preparation thereof, to the use thereof, alone or in combinations, for treatment and/or prophylaxis of diseases, and to the use thereof for production of medicaments for treatment and/or prophylaxis of diseases, especially for treatment and/or prophylaxis of lung inflammation disorders.

Abstract: The present application is directed to the field of implants comprising soft tissue for use in implantation in humans. The soft tissue implants of the present application are preferably obtained from xenograft sources. The present application provides a chemical process that sterilizes, removes antigens from and/or strengthens xenograft implants. The present techniques yield soft tissue implants having superior structural, mechanical, and/or biochemical integrity. The present application is also directed to processes for treating xenograft implants comprising soft tissues such as dermis, and to implants produced by such processes.

Abstract: There is provided an article, the article being moveable between a first position and a second position and biased to the second position. The article is retained in the first position until a predetermined condition is met, and wherein when said predetermined condition is met the article moves from the first position to the second position.

Abstract: This disclosure relates to CB1 receptor antigen-binding proteins, e.g. antibodies and methods of using the CB1 receptor antibodies. The CB1 receptor antibodies may comprise an antagonistic antibody to CB1 receptors and may be used to treat various health conditions. The health conditions can comprise obesity or diabetes or any disease that benefits from antagonism of the CB1 receptor.